A study to determine the risk of hospitalization, mechanical ventilation, and death associated with infection; and to identify characteristics independently associated with these outcomes in patients who tested positive for severe acute respiratory syndrome coronavirus 2.

Read more: inpharmd.com/covid

What does the evidence say on the safety and immunogenicity of the new Novavax vaccine for the SARS-CoV-2 infection?

Is cell phone location data associated with the rate of change in new COVID-19 cases by county across the US? Tune in to what the evidence say.

An open-label, non-randomized, single-arm, Expanded Access Program (EAP) trial conducted to explore potential signals of efficacy of COVID-19 convalescent plasma.

Read more here: inpharmd.com/covid

A prospective, multi-center, single-blind, randomized controlled phase II trial assessing the efficacy and safety of ruxolitinib in hospitalized COVID-19 patients

A cohort study published in JAMA looks at the evidence regarding race and mortality in hospitalized patients affected by COVID-19.

Let's look at the evidence to see if progressive muscle relaxation reduces anxiety and improves sleep quality in patients affected by COVID-19.

Lopinavir/ritonavir, or Kaletra™, is an antiviral theorized to work against COVID-19. Does it?